Dr. Sulaiman Al Habib Medical Services Group Company
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Saudi Arabia.
P/E ratio
30.8Investors pay 30.8 for every 1 of Dr. Sulaiman Al Habib Medical Services Group Company's yearly profit, higher than 96% of Healthcare companies in Saudi Arabia.
P/B ratio
9.02The share price is 9.02 times Dr. Sulaiman Al Habib Medical Services Group Company's book value per share, higher than 96% of Healthcare companies in Saudi Arabia.
Market cap
SAR 74.6 BThe total market value of all of Dr. Sulaiman Al Habib Medical Services Group Company's shares at today's price (share price × number of shares), larger than 96% of Healthcare companies in Saudi Arabia. PosiCap size class: Tito Cap.
Return on equity (ROE)
30.1%Dr. Sulaiman Al Habib Medical Services Group Company earned 30.1% on its shareholders' money over the last year, higher than 86% of Healthcare companies in Saudi Arabia.
Dividend yield
2.53%Dr. Sulaiman Al Habib Medical Services Group Company pays 2.53% of its share price as dividends a year, lower than 71% of dividend-paying Healthcare companies in Saudi Arabia.
Questions
What is Dr. Sulaiman Al Habib Medical Services Group Company's P/E ratio?
Investors pay 30.8 for every 1 of Dr. Sulaiman Al Habib Medical Services Group Company's yearly profit, higher than 96% of Healthcare companies in Saudi Arabia.
What is Dr. Sulaiman Al Habib Medical Services Group Company's return on equity?
Dr. Sulaiman Al Habib Medical Services Group Company earned 30.1% on its shareholders' money over the last year, higher than 86% of Healthcare companies in Saudi Arabia.
Does Dr. Sulaiman Al Habib Medical Services Group Company pay a dividend?
Yes. Dr. Sulaiman Al Habib Medical Services Group Company pays 2.53% of its share price as dividends a year, lower than 71% of dividend-paying Healthcare companies in Saudi Arabia.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.